Exact Mass: 369.3243

Exact Mass Matches: 369.3243

Found 40 metabolites which its exact mass value is equals to given mass value 369.3243, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Stearoyl GABA

4-[(1-hydroxyoctadecylidene)amino]butanoic acid

C22H43NO3 (369.3243)


N-Stearoyl GABA is also known as GABA-steatamide. N-Stearoyl GABA is considered to be practically insoluble (in water) and acidic. N-Stearoyl GABA is a fatty amide lipid molecule

   

N-Palmitoyl Isoleucine

2-(Hexadecanoylamino)-3-methylpentanoic acid

C22H43NO3 (369.3243)


N-palmitoyl isoleucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Isoleucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Isoleucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Isoleucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Palmitoyl Leucine

2-(Hexadecanoylamino)-4-methylpentanoic acid

C22H43NO3 (369.3243)


N-palmitoyl leucine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Leucine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Leucine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Leucine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Semiplenamide F

N-(2-methyl-2S,3R-epoxy-octadecanoyl)-1-hydroxypropyl-2-amine

C22H43NO3 (369.3243)


   

Arachidoyl glycine

N-(1-oxoeicosyl)-glycine

C22H43NO3 (369.3243)


   

Aplidiasphingosine

2S-amino-5,9,13,17-tetramethyl-8E,16-octadecadiene-1,3R,14-triol

C22H43NO3 (369.3243)


An amino alcohol that is 2-aminooctadeca-8,16-diene-1,3,14-triol substituted by methyl groups at positions 5, 9, 13 and 17 (the 2S,3R,8E stereoisomer).

   

3-[(2R,3aS,6S,6aS)-6-tetradecylhexahydrofuro[3,4-d]oxazol-2-yl]-1-propanol|jaspine A

3-[(2R,3aS,6S,6aS)-6-tetradecylhexahydrofuro[3,4-d]oxazol-2-yl]-1-propanol|jaspine A

C22H43NO3 (369.3243)


   

N-stearoyl GABA

N-octadecanoyl-gamma-aminobutyric acid

C22H43NO3 (369.3243)


   

N-palmitoyl isoleucine

N-hexadecanoyl-isoleucine

C22H43NO3 (369.3243)


   

N-palmitoyl leucine

N-hexadecanoyl-leucine

C22H43NO3 (369.3243)


   

NA 22:1;O2

N-octadecanoyl-gamma-aminobutyric acid

C22H43NO3 (369.3243)


   

oleic acid, compound with morpholine (1:1)

oleic acid, compound with morpholine (1:1)

C22H43NO3 (369.3243)


   

C4 Ceramide (d18:1/4:0)

C4 Ceramide (d18:1/4:0)

C22H43NO3 (369.3243)


   

N,N-Diethanololeamide

N,N-Diethanololeamide

C22H43NO3 (369.3243)


   

Palmitoyl isoleucine

Palmitoyl isoleucine

C22H43NO3 (369.3243)


   

N-butyroyl-D-erythro-sphingosine

N-butyroyl-D-erythro-sphingosine

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]acetamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]nonanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]nonanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]octanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]tridecanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]tridecanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]pentanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]heptanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]hexanamide

C22H43NO3 (369.3243)


   

(Z)-N-(1,3-dihydroxynonan-2-yl)tridec-9-enamide

(Z)-N-(1,3-dihydroxynonan-2-yl)tridec-9-enamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetradecanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetradecanamide

C22H43NO3 (369.3243)


   

(Z)-N-(1,3-dihydroxyoctan-2-yl)tetradec-9-enamide

(Z)-N-(1,3-dihydroxyoctan-2-yl)tetradec-9-enamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]propanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]dodecanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]dodecanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]undecanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]undecanamide

C22H43NO3 (369.3243)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]decanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]decanamide

C22H43NO3 (369.3243)


   
   
   
   
   
   

(2s,3r)-n-[(2r)-1-hydroxypropan-2-yl]-2-methyl-3-pentadecyloxirane-2-carboximidic acid

(2s,3r)-n-[(2r)-1-hydroxypropan-2-yl]-2-methyl-3-pentadecyloxirane-2-carboximidic acid

C22H43NO3 (369.3243)


   

(2r,3r,6s)-6-(13-hydroxytetradecyl)-2-methylpiperidin-3-yl acetate

(2r,3r,6s)-6-(13-hydroxytetradecyl)-2-methylpiperidin-3-yl acetate

C22H43NO3 (369.3243)


   

n-(1-hydroxypropan-2-yl)-2-methyl-3-pentadecyloxirane-2-carboximidic acid

n-(1-hydroxypropan-2-yl)-2-methyl-3-pentadecyloxirane-2-carboximidic acid

C22H43NO3 (369.3243)


   

(2s,3r)-n-(1-hydroxypropan-2-yl)-2-methyl-3-pentadecyloxirane-2-carboximidic acid

(2s,3r)-n-(1-hydroxypropan-2-yl)-2-methyl-3-pentadecyloxirane-2-carboximidic acid

C22H43NO3 (369.3243)